{{pageTitle}}

New 5D Publication

11-Apr-2018

 

Assessment of clinical effectiveness of haemoglobin spray as adjunctive therapy in the treatment of sloughy wounds

 

 

Sharon D Hunt, Fredrik Elg, Steven L Percival

 

Journal of Wound Care | Vol. 27 | No. 4 | pp 210–219 


Objective: To assess use of an adjunctive topical haemoglobin spray in the treatment of sloughy wounds.

Results: After 26 weeks, 94/100 patients (94%) treated with haemoglobin spray were completely healed compared with 63/100 control patients (63%). Positive results were evident as early as week one with 52% mean wound size reduction using the heamoglobin spray versus 11% in the retrospective control (p<0.001). At baseline, mean slough coverage was higher in the haemoglobin group, 58% versus 44% in the control group (p<0.001). By week four, mean slough coverage was 1% in the haemoglobin versus 29% in the control group (p<0.001). Reductions in exudate and pain levels (p<0.001) were also observed.

Conclusion: Overall, results of this evaluation showed the addition of adjunctive haemoglobin spray to standard wound care treatment achieved positive clinical outcomes for patients self-managing complicated sloughy wounds, by supporting reduction of wound exudate and slough within the complex multifaceted process of wound healing.


 

NEWS

Global Health & Pharma (''GHP'') Recognises 5D As The Best Global Microbiology Laboratory 2019 2019 30 AUG

WINNER! Global Health & Pharma (''GHP'') Recognises 5D Health Protection Group Ltd As ..

5D CEO Acknowledged As One of the World's Leading Experts on Biofilms and Also Wound Infections 2019 29 AUG

Wonderful to see our CEO Prof Steven Percival being acknowledged as one of the top world e..

Read More News